• Prescribing Information
    RYBREVANT® Prescribing InformationRYBREVANT® Información de PrescripciónLAZCLUZE™ Prescribing InformationLAZCLUZE™ Información de Prescripción
  • Important Safety Information
  • Medical Information
  • For US Patients
  • Register for Updates
  • Find a J&J Specialist
  • This site is intended for
    US healthcare professionals.
  • For US Healthcare Professionals
RYBREVANT® (amivantamab) logo
For APPs & Nurses
  • Unmet Needs
  • Mechanism of Action
  • Clinical Trial Results
    Dosage & Administration
    Therapy Management
    Support & Resources
    For APPs & Nurses
    • Prescribing Information
      RYBREVANT® Prescribing InformationRYBREVANT® Información de PrescripciónLAZCLUZE™ Prescribing InformationLAZCLUZE™ Información de Prescripción
    • Important Safety Information
    • Medical Information
    • For US Patients
    • Register for Updates
    • Find a J&J Specialist
    • This site is intended for
      US healthcare professionals.

SITEMAP

Home
Unmet Needs
Mechanism of Action

Clinical Trial Results

First-Line EGFR+ mNSCLC
Second-Line EGFR+ mNSCLC
First-Line EGFR+ Exon20ins mNSCLC

Dosage & Administration

Dosing Schedule
Administration

Therapy Management

Warnings & Precautions
Monitoring & Management
Proactive Supportive Care

Support & Resources

HCP & Access Support
Patient Support
For APPs & Nurses